CClinicalTrials.gg
Active, not recruitingNCT06800924SPINALANUpdated Mar 30, 2026

Posture and Spinal Mobility in Anorexia Nervosa

An observational study in Anorexia Nervosa, sponsored by Istituto Auxologico Italiano. Active, not recruiting at 1 site in Italy. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-30.

Sponsored by Istituto Auxologico Italiano · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
60
Ages
18 Years and older
Sex
Female
01

Study summary

The primary objective of the study is to compare the results of the postural and mobility analysis obtained with the use of the Idiag M360 instrument in adult women with anorexia nervosa and in a control group represented by age-matched normal-weight women.

Secondary objectives will be to correlate the results obtained from previous postural analyses with anthropometric parameters, the duration and onset of the disease, and the presence/date of onset of secondary amenorrhea.

02

Conditions studied

  • Anorexia Nervosa

Browse trials for

Keywords

  • Anorexia nervosa
  • Spinal mobility
  • Posture
03

In context

Anorexia Nervosa

455 studies on the registry are indexed under Anorexia Nervosa; 126 are open to participants now.

This study's enrollment of 60 is below the median of 72 across 135 observational studies indexed under Anorexia Nervosa.

Browse Anorexia Nervosa studies →

Lead sponsor

Istituto Auxologico Italiano is the lead sponsor of 196 studies on the registry; 78 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The subjects admitted to the study will be recruited at the beginning of hospitalization in the Division of Eating and Nutrition Disorders (END), Istituto Auxologico Italiano, IRCCS, Piancavallo (VB), Italy. Thirty women suffering from anorexia nervosa clinically diagnosed based on the DSM-5 criteria (Diagnostic and Statistical Manual of Mental Disorders 5; American Psychiatric Association, 2013), aged ≥ 18 years, will be studied.

As a control group, 30 normal-weight adult women (age: ≥ 18 years; BMI: 18.5-24.9 kg/m2) will be recruited from the medical/nursing and research staff.

Eligibility criteria

Anorexia Nervosa:

Inclusion Criteria:

  • Female sex
  • Age 18 years and older
  • Anorexia nervosa clinically diagnosed based on the DSM-5 criteria
  • Hospitalized in the Division of Eating and Nutrition Disorders (END), Istituto Auxologico Italiano, IRCCS, Piancavallo (VB), Italy

Exclusion Criteria:

  • Absence of signed informed consent
  • Musculoskeletal or neurological conditions (leg length discrepancy, spinal deformities, and physical disabilities caused by surgery)
  • Treatment with anti-inflammatory drugs

Normal Weight:

Inclusion Criteria:

  • Female sex
  • Age 18 years and older
  • BMI: 18.5-24.9 kg/m2
  • Recruited from the medical/nursing and research staff

Exclusion Criteria:

  • Absence of signed informed consent
  • Musculoskeletal or neurological conditions (leg length discrepancy, spinal deformities, and physical disabilities caused by surgery)
  • Treatment with anti-inflammatory drugs
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
60 participants (actual)
Patient registry
No

Groups and cohorts

  • Anorexia Nervosa

    Women suffering from anorexia nervosa clinically diagnosed based on the DSM-5 criteria (Diagnostic and Statistical Manual of Mental Disorders 5; American Psychiatric Association, 2013), aged ≥ 18 years

    Other: Postural and mobility analysis

  • Normal weight

    Normal-weight adult women (age: ≥ 18 years; BMI: 18.5-24.9 kg/m2), recruited from the medical/nursing and research staff.

    Other: Postural and mobility analysis

Interventions

  • OtherPostural and mobility analysis

    Postural and mobility parameters were obtained with the use of the Idiag M360 scan tool (Idiag, Fehraltorf, Switzerland)

06

What researchers measure

Primary outcomes

  1. Lateral flexion

    Idiag M360 scan tool (Idiag, Fehraltorf, Switzerland); flexion expressed in degrees

    Time frame: Baseline

  2. Lumbar flexion

    IIdiag M360 scan tool (Idiag, Fehraltorf, Switzerland); flexion expressed in degrees

    Time frame: Baseline

  3. Lumbar extension

    IIdiag M360 scan tool (Idiag, Fehraltorf, Switzerland); extension expressed in degrees

    Time frame: Baseline

  4. Thoracic extension

    IIdiag M360 scan tool (Idiag, Fehraltorf, Switzerland); extension expressed in degrees

    Time frame: Baseline

07

Study locations

1 site
  • Istituto Auxologico Italiano IRCCS, Site Piancavallo
    Oggebbio, Verbania 28824, Italy
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06800924
Lead sponsor
Istituto Auxologico Italiano
Responsible party
Sponsor
First posted
Jan 30, 2025
Start date
Jun 6, 2024
Primary completion
Oct 16, 2024
Completion
Jun 30, 2026 (estimated)
Last update
Mar 30, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion